AEE-788 Completed Phase 1 Trials for Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00118456
Study of Oral AEE788 in Adults With Advanced Cancer